Markets:

Overview

News

Currencies

International

Treasuries

Illumina, Inc. - Common Stock (NQ:ILMN)

116.81 +2.37 (+2.07%)

Streaming Delayed Price Updated: 4:00 PM EST, Feb 13, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Illumina, Inc. - Common Stock

< Previous 1 2

...

5 6 7 8 9 10 11 12 13

...

25 26 Next >

This Starbucks Analyst Turns Bullish; Here Are Top 5 Upgrades For Wednesday ↗

August 14, 2024

Via Benzinga

Expert Outlook: Illumina Through The Eyes Of 13 Analysts ↗

August 13, 2024

Via Benzinga

Wall Street Poised For Second Day Of Gains While Bank Of Japan Makes Reassurances; Dollar Strengthens Against Yen, Crude Prices Surge: What's Driving Markets Wednesday? ↗

August 07, 2024

The U.S.

Via Benzinga

Illumina Analysts Increase Their Forecasts Following Strong Q2 Results ↗

August 07, 2024

Via Benzinga

Peering Into Illumina's Recent Short Interest ↗

July 31, 2024

Via Benzinga

$1000 Invested In Illumina 20 Years Ago Would Be Worth This Much Today ↗

July 18, 2024

Via Benzinga

Shopify Posts Upbeat Earnings, Joins Axon Enterprise, Aspen Technology, Illumina, Global Payments And Other Big Stocks Moving Higher On Wednesday ↗

August 07, 2024

Via Benzinga

US Stocks Set To Extend Gains Despite Mixed Earnings, VIX Dips Back Toward Pre-Sell-Off Levels: Analyst Says Pullback Is A 'Growth Scare' And Not 'Calamity' ↗

August 07, 2024

Wall Street could go from strength to strength as the index futures point to another session in the green as investors seek to put the worst behind. Volatility continued to drop, as evidenced by...

Via Benzinga

Topics Stocks

Here's How Much You Would Have Made Owning Illumina Stock In The Last 20 Years ↗

July 12, 2024

Via Benzinga

A Glimpse Into The Expert Outlook On Illumina Through 10 Analysts ↗

July 01, 2024

Via Benzinga

ILMN Stock Earnings: Illumina Misses EPS, Beats Revenue for Q2 2024 ↗

August 06, 2024

ILMN stock results show that Illumina missed analyst estimates for earnings per share but beat on revenue for the second quarter of 2024.

Via InvestorPlace

Wall Street Rebounds After Selloff, VIX Falls, Dollar Surges Against Yen: What's Driving Markets Tuesday? ↗

August 06, 2024

U.S. stock markets saw a strong recovery on Tuesday, with both the S&P 500 and the Nasdaq 100 climbing over 2%, nearly offsetting Monday’s losses. Investors took advantage of recent volatility to buy...

Via Benzinga

Topics Economy Stocks

Second-Quarter 2024 Thematic Growth Update ↗

August 01, 2024

The second quarter saw stocks move higher again, reaching levels that seem overly stretched from a fundamental and technical standpoint. The market has seen a significant rotation into mega-cap stocks,...

Via Talk Markets

US Stocks Set To Open Higher After Monday's Crash, VIX Plummets: Analyst Says Would Have Worried If Market Surged Higher Without Correction ↗

August 06, 2024

Strong sell-off may be viewed as an opportunity to load up beaten-down stocks but traders may seek evidence regarding sustainability of uptrend.

Via Benzinga

Topics Stocks

Jim Cramer Says No To This Health Care Stock, Recommends Holding On To Constellation Energy: 'It's Up A Huge Amount' ↗

July 30, 2024

Jim Cramer said Constellation Energy is a "solar play that is a very good company. It's up a huge amount versus a lot of other stocks."

Via Benzinga

Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet ↗

July 26, 2024

The Benzinga Stock Whisper highlights five stocks seeing increased interest across the Benzinga ecosystem using proprietary data.

Via Benzinga

3 Precision Medicine Stocks Tailoring Treatments ↗

July 21, 2024

With technological developments pushing the boundaries of healthcare, these are the precision medicine stocks to consider.

Via InvestorPlace

3 Spinoff Stocks You Should Buy Now: July 2024 ↗

July 15, 2024

Spinoff stocks often take time to gain their footing in the market giving investors an opportunity to get in early.

Via InvestorPlace

What's Going On With 10x Genomics Stock On Wednesday? ↗

July 10, 2024

Illumina acquires Fluent BioSciences to enhance single-cell analysis and multiomics research. 10x Genomics faces challenges as shares drop amid competitive pricing pressures in the single-cell market.

Via Benzinga

Illumina Buys Fluent BioSciences To Gain Stronger Foothold In Single-Cell Analysis ↗

July 10, 2024

Illumina has acquired Fluent BioSciences, enhancing its single-cell analysis and multiomics capabilities. Fluent's innovative technology, including the PIPseq V system, offers cost-effective and...

Via Benzinga

SMART Global Posts Upbeat Results, Joins Aehr Test Systems, MarineMax And Other Big Stocks Moving Higher On Wednesday ↗

July 10, 2024

Via Benzinga

3 Of the Best ETFs to Buy for AI Stocks Exposure ↗

July 09, 2024

One of the best ways to gain max exposure to the unstoppable artificial intelligence boom is with popular AI ETFs.

Via InvestorPlace

Topics Artificial Intelligence ETFs

The 3 Best Gene Editing Stocks to Buy in July 2024 ↗

July 08, 2024

Gene editing is revolutionizing medicine, creating substantial opportunities for some of the best gene editing stocks.

Via InvestorPlace

3 Biotech Stocks Turning DNA Dreams Into Dollars ↗

July 05, 2024

Investors should consider buying into one of the future avenues of medicine by investing in these three BNA biotech stocks.

Via InvestorPlace

The 3 Best Personalized Medicine Stocks to Buy in July 2024 ↗

July 03, 2024

Explore promising personalized medicine stocks poised for growth as the industry expands, driven by advancements in genomic technologies.

Via InvestorPlace

GRAL Stock Alert: 7 Things to Know as Grail Starts Trading Today ↗

June 25, 2024

New biotech stock Grail begins trading on the Nasdaq today. Here's what investors need to know about GRAL stock.

Via InvestorPlace

Once Valued At Around $7B, Cancer Blood Test Developer Grail To Kickstart Trading On NASDAQ ↗

June 25, 2024

Illumina spins off Grail, making Grail an independent public company. Shareholders receive one GRAIL share per six Illumina shares. Illumina retains a 14.5% stake.

Via Benzinga

Large-Cap Stocks In Trouble: Here Are The 10 Worst Performers Over The Past 12 Months - Sunday, June 23 ↗

June 23, 2024

Over the past twelve months, 10 large-cap stocks have underperformed all others. Here's a brief look at these underperforming stocks.

Via Talk Markets

3 Stocks to Buy That Are NOT in the S&P 500 (but Should Be) ↗

June 20, 2024

Companies not yet in the S&P 500 but whose businesses are doing well make excellent stocks to buy. Here are three examples.

Via InvestorPlace

Topics Stocks

Meet the Newest Artificial Intelligence (AI) Stock in the S&P 500. It's Up 266% Since Last Year, and Wall Street Says It's Still a Buy Today ↗

June 18, 2024

The cybersecurity leader is building on existing advantages using AI innovations.

Via The Motley Fool

Topics Artificial Intelligence Stocks

< Previous 1 2

...

5 6 7 8 9 10 11 12 13

...

25 26 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Illumina, Inc. - Common Stock (NQ:ILMN)

Headline News about Illumina, Inc. - Common Stock

Starting at $3.75/week.

Subscribe Today